Ethyl bromoacetate → HCID 22393126, compound
Reaction equation
[O:1]=[S:2]1(=[O:26])[C:8]2[CH:9]=[CH:10][C:11]([OH:13])=[CH:12][C:7]=2[N:6]([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[CH2:5][C:4]([CH2:22][CH2:23][CH2:24][CH3:25])([CH2:20][CH3:21])[CH2:3]1.Br[CH2:28][C:29]([O:31][CH2:32][CH3:33])=[O:30].C(=O)([O-])[O-].[Na+].[Na+]>[Br-].C([N+](CCCC)(CCCC)CCCC)CCC.CC#N>[O:26]=[S:2]1(=[O:1])[C:8]2[CH:9]=[CH:10][C:11]([O:13][CH2:28][C:29]([O:31][CH2:32][CH3:33])=[O:30])=[CH:12][C:7]=2[N:6]([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[CH2:5][C:4]([CH2:22][CH2:23][CH2:24][CH3:25])([CH2:20][CH3:21])[CH2:3]1Participants
6
Procedure
1,1-Dioxo-3-butyl-3-ethyl-5-phenyl-7-hydroxy-2,3,4,5-tetrahydro-1,5-benzothiazepine (WO 96/16051; 100 mg, 0.27 mmol), ethyl bromoacetate (50 mg, 0.30 mmol), sodium carbonate (100 mg, 0.94 mmol) and tetrabutylammonium bromide (10 mg 0.031 mmol) were added to MeCN (4 ml). The mixture was refluxed for 20 h and then evaporated under reduced pressure. The residue was purified by column chromatography on silica gel. The product was eluted with DCM: ethyl acetate (50:50). 120 mg (97%) of the title compound was obtained. NMR (300 MHz): 0.7-0.9 (m, 6H), 1.0-1.8 (m, 11H), 3.1-3.25 (m, 2H), 3.6-3.8 (m, 2H), 4.3 (q, 2H), 4.6 (s, 2H), 6.9-7.1 (m, 5H), 7.2-7.3 (m, 2H), 7.5 (d, 1H).
Workup
- temperatureThe mixture was refluxed for 20 h
- customevaporated under reduced pressure
- customThe residue was purified by column chromatography on silica gel
- washThe product was eluted with DCM: ethyl acetate (50:50)
Sources & evidence
- ORD record
- ord-093dd8bd910949d6bedfdff4fc6d6ba5
- Source dataset
- uspto-grants-2005_06
- Patent number
- US06906058B2
Reaction notes
Loading…